Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance
Willing to provide written and dated informed consent to participate in the study.
Willing and able to comply with the protocol.
Are not on any medication, or supplements which would impact the trial in the opinions of the investigator or Sponsor.
Male or female between 18 and 45 years of age (18.5 kg/m2 ≥ BMI < 30 kg/m2).
Subjects having a known allergy or hypersensitivity to any of the ingredients in the investigational products.
Subjects with a history of alcohol and/or other drug abuse in the past year.
Has performed strenuous exercise (rating of perceived exertion ≥ 13) ≤ 48 hours before laboratory visit (Borg, 1982).
Consuming >14 alcoholic drinks per week or > 2 drinks/day in the 48 hours preceding a clinic visit.
Nuritas Ltd
Lead sponsor
Australian Catholic University
Collaborator
Baker Heart and Diabetes Institute
Collaborator